Barclays Boosts Hikma Pharmaceuticals (OTCMKTS:HKMPF) Price Target to GBX 1,800

Hikma Pharmaceuticals (OTCMKTS:HKMPF – Free Report) had its price objective increased by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research note issued to investors on Wednesday morning, FlyOnTheWall reports. Separately, Royal Bank of Canada increased their price objective on Hikma Pharmaceuticals from GBX 1,950 ($25.09) to GBX 2,050 ($26.37) in a […]

Related Keywords

Canada ,United States ,America , ,Royal Bank ,Analyst Recommendations For Hikma Pharmaceuticals ,Hikma Pharmaceuticals Price Performance ,Barclays ,News Ratings For Hikma Pharmaceuticals Daily ,Hikma Pharmaceuticals ,Free Report ,Moderate Buy ,Get Free Report ,North America ,Middle East ,North Africa ,Hikma Pharmaceuticals Daily ,Otcmkts Hkmpf ,Hkmpf ,Medical ,Boost Price Target ,Barclays Plc ,